✦ LIBER ✦

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries

✍ Scribed by Sandra E. Talbird; Thomas N. Taylor; Stefanie Knoll; Carl Richard Frostad; Sebastián García Martí

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to “Outcomes and costs associat

✍ David Strutton; Sharon Hwang; Raymond Farkouh; Craig Roberts 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Reply to Strutton et al.: Response to “O

✍ Sandra Talbird; Gerhart Knerer; William Hausdorff; Tom Taylor; Carl Richard Fros 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 132 KB

PIN47 MODELING THE OUTCOMES OF VACCINATI

✍ Mares, J; Moraga-Llop, F; Fenoll, A; Pérez-Alcántara, F; Pérez, I; Morano, R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

VA2 COST EFFECTIVENESS ANALYSIS OF THE N

✍ AS Ismaila; JA Pereira; RC Robson; SD Simpson; NS Rawson; BA Standaert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PIH18 A COST EFFECTIVENESS ANALYSIS OF A

✍ A Bergman; S Borg; P Sobocki; U Persson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Safety and Reactogenicity of a 10-Valent

✍ N. Bermal; E. Alberto; M. Hernandez; V. Pau; A. Fanic; H. Bock; I. Dieussaert; L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB